Search research articles
Contact Us
Filters
Showing results (341-350 of 419) with videos related to
Page
of 42
Sort By:
European Urology Focus
|
July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples
Yiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo, Xuan Wang, Kaitlin M Woo, et al.
JAMA Oncology
|
July 7, 2018
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma
Maria I Carlo, Semanti Mukherjee, Diana Mandelker, et al.
Nature Immunology
|
July 28, 2022
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine
Ramin Sedaghat Herati, David A Knorr, Laura A Vella, et al.
European Urology Oncology
|
August 6, 2024
Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery
Jennifer Ma, Luke Del Balzo, Henry Walch, et al.
Cell Reports. Medicine
|
October 31, 2025
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling
Pavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Genome Biology
|
November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Genome Biology
|
March 3, 2017
Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Cancer Cell
|
April 16, 2021
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
Chirag Krishna, Renzo G DiNatale, Fengshen Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Page
of 42
Search research articles
Search
Showing results (341-350 of 419) with videos related to
Sort By:
Page
of 42
European Urology Focus
|
July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples
Yiyu Dong, Brandon J Manley, Maria F Becerra, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 21, 2016
Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy
Jarushka Naidoo, Xuan Wang, Kaitlin M Woo, et al.
JAMA Oncology
|
July 7, 2018
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma
Maria I Carlo, Semanti Mukherjee, Diana Mandelker, et al.
Nature Immunology
|
July 28, 2022
PD-1 directed immunotherapy alters Tfh and humoral immune responses to seasonal influenza vaccine
Ramin Sedaghat Herati, David A Knorr, Laura A Vella, et al.
European Urology Oncology
|
August 6, 2024
Clinical Outcomes and Targeted Genomic Analysis of Renal Cell Carcinoma Brain Metastases Treated with Stereotactic Radiosurgery
Jennifer Ma, Luke Del Balzo, Henry Walch, et al.
Cell Reports. Medicine
|
October 31, 2025
Identification of therapeutic targets for renal medullary carcinoma via integrated genomic and transcriptomic profiling
Pavlos Msaouel, Nizar M Tannir, Funda Meric-Bernstam, et al.
Genome Biology
|
November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Genome Biology
|
March 3, 2017
Erratum to: Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures
Yasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Cancer Cell
|
April 16, 2021
Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy
Chirag Krishna, Renzo G DiNatale, Fengshen Kuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2017
The PARP Inhibitor Veliparib Can Be Safely Added to Bendamustine and Rituximab and Has Preliminary Evidence of Activity in B-Cell Lymphoma
Jacob D Soumerai, Andrew D Zelenetz, Craig H Moskowitz, et al.
Page
of 42